The ABHA Lab (simply pronounced as "ABA") is directed by Roger Vilardaga Viera. The focus of the lab is to ideate, develop, and test digital behavioral health interventions to increase access to behavioral health among high priority populations. This includes individuals who experience persistent mental health symptoms, HIV, addiction, chronic pain, and racial and ethnic minorities at the intersection of those conditions.

The lab specializes in:

  • Designing digital tools to foster behavioral health and psychological flexibility,
  • Applying rigorous multi-method strategies to evaluate them, and
  • Using a health equity framework to inform their real world implementation.

The lab has received funding from the National Institute on Drug Abuse, the University of Washington Innovation Award, Pfizer, and the National Cancer Institute.

Highlighted Publications

Review of strategies to investigate low sample return rates in remote tobacco trials: A call to action for more user-centered design research. Vilardaga, R., Thrul, J., DeVito, A., Sabo, P., Cohab Khafif, T. Addiction Neuroscience, View Article

The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who Smoke. Cioe PA, Schnoll R, Hoeppner BB, Gross R, Hitsman BL, Leone FT, Ashare R, Vilardaga R, Tashima K, Pinkston M, Kahler CW. AIDS Behav. View Article